Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft

Vascular and Endovascular Surgery

Volumn 47, Issue 7, 2013, Pages 502-506

  Jebran, A Fawad ^a   Popov, Aron F ^a   Zenker, Dieter ^a   Bireta, Christian ^a   Friedrich, Martin ^a   Danner, Bernhard C ^a   Bougioukas, Ioannis ^a   Schoendube, Friedrich A ^a   Stojanovic, Tomislav ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Wolfsburg City Hospital   (Germany)

Author keywords

ankle brachial index; endovascular; lower extremities; superficial femoral artery disease; surgical above knee bypass; Viabahn

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ABOVE KNEE PROSTHESIS; ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT PATENCY; HUMAN; MALE; RISK FACTOR; SUPERFICIAL FEMORAL ARTERY OCCLUSION; SUPERFICIAL FEMORAL ARTERY STENT; VIABAN ENDOPROSTHESIS;

ANKLE BRACHIAL INDEX; ENDOVASCULAR; LOWER EXTREMITIES; SUPERFICIAL FEMORAL ARTERY DISEASE; SURGICAL ABOVE-KNEE BYPASS; VIABAHN;

AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84884569359     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574413495964     Document Type: Article

References (27)

1. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized, multicenter study comparing expanded polytetra-fluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol. 2008 ; 19 (6). 823-832
2. Gable D. Role of total endoluminal superficial femoral artery bypass. J Cardiovasc Surg (Torino). 2011 ; 52 (5). 683-700
3. Lammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000 ; 217 (1). 95-104
4. McQuade K, Gable D, Hohman S, Pearl G, Theune B.. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2009 ; 49 (1). 109 e1-115 9
5. Jahnke T, Andresen R, Müller-Hülsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol. 2003 ; 14 (1). 41-51
6. Fischer M, Schwabe C, Schulte KL. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther. 2006 ; 13 (3). 281-290
7. Hartung O, Otero A, Dubuc M, et al. Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants. Eur J Vasc Endovasc Surg. 2005 ; 30 (3). 300-306
8. Alimi YS, Hakam Z, Hartung O, et al. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?. Eur J Vasc Endovasc Surg. 2008 ; 35 (3). 346-352
9. Farraj N, Srivastava A, Pershad A. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft. J Invasive Cardiol. 2009 ; 21 (6). 278-281
10. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D.. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg. 2007 ; 45 (1). 10-16
11. McQuade K, Gable D, Pearl G, Theune B, Black S. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2010 ; 52 (3). 584-590
12. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997 ; 26 (3). 517-538
13. Kumar K, Crinnion JN, Ashley WG, Gough MJ. Conduit of choice for above-knee femoropopliteal bypass. British J Surg.. 1995 ; 82 (4). 556
14. Donker JM, Ho GH, Te Slaa A, et al. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease. Vasc Endovascular Surg. 2011 ; 45 (7). 598-603
15. Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003 ; 37 (1). 149-155
16. Dorigo W, Pulli R, Piffaretti G, et al. Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses. J Cardiovasc Surg (Torino). 2012 ; 53 (2). 187-194
17. Tilanus HW, Obertop H, Van Urk H.. Saphenous vein or PTFE for femoropopliteal bypass. A prospective randomized trial. Ann Surg. 1985 ; 202 (6). 780-782
18. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004 ; 27 (4). 357-362
19. Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting. J Vasc Surg. 2010 ; 52 (1). 232-236
20. Abbott WM, Green RM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J Vasc Surg. 1997 ; 25 (1). 19-28
21. Met R, Van Lienden KP, Koelemay MJ, Bipat S, Legemate DA, Reekers JA. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol. 2008 ; 31 (4). 687-697
22. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006 ; 354 (18). 1879-1888
23. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012 ; 19 (1). 1-9
24. Dick P, Wallner H, Sabeti S, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009 ; 74 (7). 1090-1095
25. Schlager O, Dick P, Sabeti S, et al. Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther. 2005 ; 12 (6). 676-684
26. Saxon RR, Coffman JM, Gooding JM, Ponec DJ. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol. 2007 ; 18 (11). 1341-1349
27. Lenti M, Cieri E, De Rango P, et al. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent. J Vasc Surg. 2007 ; 45 (1). 32-39